title: Antiviral treatment for cirrhosis due to hepatitis C: a review.
abstract: Chronic hepatitis C infection is an important cause of cirrhosis and hepatocellular carcinoma (HCC). Antiviral therapy (AVT) for patients with cirrhosis due to hepatitis C may retard the progression of cirrhosis and prevent both the development of HCC as well as the recurrence of hepatitis C following liver transplantation. This review highlights the issues associated with AVT for patients with compensated and decompensated cirrhosis due to hepatitis C virus.
authors.affiliation: Department of Gastroenterology and Hepatology, Stanley Medical College and Hospital, Chennai 600001, India. aravindhsom@gmail.com
authors.forename: Aravindh
authors.initials: A
authors.lastname: Somasundaram
authors.forename: Jayanthi
authors.initials: J
authors.lastname: Venkataraman
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology; D018450:Disease Progression; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology; D016031:Liver Transplantation; D055502:Secondary Prevention
chemical_list: D000998:Antiviral Agents